JO2031B1 - عنوان الاختراع: - Google Patents

عنوان الاختراع:

Info

Publication number
JO2031B1
JO2031B1 JO19982031A JOP19982031A JO2031B1 JO 2031 B1 JO2031 B1 JO 2031B1 JO 19982031 A JO19982031 A JO 19982031A JO P19982031 A JOP19982031 A JO P19982031A JO 2031 B1 JO2031 B1 JO 2031B1
Authority
JO
Jordan
Prior art keywords
tetrahydropyridine
tetrazol
ethyl
methyl
acid addition
Prior art date
Application number
JO19982031A
Other languages
English (en)
Inventor
بيك سومير مايكل
نيلسين أولي
Original Assignee
إتش لوندبيك إيه /إس
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by إتش لوندبيك إيه /إس filed Critical إتش لوندبيك إيه /إس
Application granted granted Critical
Publication of JO2031B1 publication Critical patent/JO2031B1/ar

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

يتعلق الاختراع الحالي بالملح الاضافي لحمض المالييك للمركب 5- (2- ايثيل -2 يد – تترازول -5 يال )-1 – ميثيل -1 ، 2، 3، 6 – تتراهيدروبيريدين ، وبالمركبات الصيدلانية (الدوائية) المحتوية على الملح الاضافي للحمض واستخدامه لمعالجة الاضطرابات الناتجة عن سوء استخدام نظام الاستيل كولين (Ac Ch) او النظام المسكريني .
JO19982031A 1997-07-01 1998-06-25 عنوان الاختراع: JO2031B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01

Publications (1)

Publication Number Publication Date
JO2031B1 true JO2031B1 (ar) 1999-05-15

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
JO19982031A JO2031B1 (ar) 1997-07-01 1998-06-25 عنوان الاختراع:

Country Status (25)

Country Link
EP (1) EP0994869A1 (ar)
JP (1) JP2002507215A (ar)
KR (1) KR20010014297A (ar)
CN (1) CN1261361A (ar)
AR (1) AR013096A1 (ar)
AU (1) AU735751B2 (ar)
BG (1) BG103933A (ar)
BR (1) BR9810331A (ar)
CA (1) CA2293324A1 (ar)
CO (1) CO4940483A1 (ar)
EA (1) EA200000081A1 (ar)
HU (1) HUP0002876A2 (ar)
IL (1) IL133093A0 (ar)
IS (1) IS5278A (ar)
JO (1) JO2031B1 (ar)
MA (1) MA25138A1 (ar)
NO (1) NO996580L (ar)
PE (1) PE116099A1 (ar)
PL (1) PL337184A1 (ar)
SK (1) SK187399A3 (ar)
TN (1) TNSN98120A1 (ar)
TR (1) TR199903283T2 (ar)
UY (2) UY25069A1 (ar)
WO (1) WO1999001448A1 (ar)
ZA (1) ZA985498B (ar)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
JPH11514654A (ja) * 1995-11-06 1999-12-14 ハー・ルンドベック・アクチェゼルスカベット 外傷による脳損傷の治療方法

Also Published As

Publication number Publication date
TNSN98120A1 (fr) 2005-03-15
UY25177A1 (es) 2000-12-29
HUP0002876A2 (hu) 2001-06-28
PL337184A1 (en) 2000-08-14
SK187399A3 (en) 2000-06-12
IS5278A (is) 1999-11-30
WO1999001448A1 (en) 1999-01-14
UY25069A1 (es) 1998-12-21
CA2293324A1 (en) 1999-01-14
BR9810331A (pt) 2000-09-05
IL133093A0 (en) 2001-03-19
CO4940483A1 (es) 2000-07-24
EP0994869A1 (en) 2000-04-26
PE116099A1 (es) 1999-11-23
AU735751B2 (en) 2001-07-12
AU8102098A (en) 1999-01-25
MA25138A1 (fr) 2001-04-02
CN1261361A (zh) 2000-07-26
JP2002507215A (ja) 2002-03-05
EA200000081A1 (ru) 2000-08-28
NO996580D0 (no) 1999-12-30
KR20010014297A (ko) 2001-02-26
NO996580L (no) 1999-12-30
ZA985498B (en) 1999-01-20
AR013096A1 (es) 2000-12-13
BG103933A (en) 2000-07-31
TR199903283T2 (xx) 2000-06-21

Similar Documents

Publication Publication Date Title
CA2198238A1 (en) Piperidine derivatives as neurokinin antagonists
EP0896533A4 (en) PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS
GEP20043303B (en) Polycycloalkylpurines as Adenosine Receptor Antagonists
BG103297A (en) Aralkyl and aralkyliden heterocyclic lactams and imides
NZ329627A (en) 8-Heterocyclically substituted 1,3,8-triaza-spiro[4.5]decan-4-ones
MX9605741A (es) Clorhidrato cristalino del (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil ]-aminometil} cromano.
CA2090220A1 (en) Treatment of non-inflammatory and non-infectious bowel disorders
PL374325A1 (en) Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof
HUT71550A (en) Pharmaceutical agents containing quinuclidine, piperidine or azanorbornane derivatives for treatment of emesis
TR200101962T2 (tr) Sindirim sistemi bozukluklarını tedavi etmek için 4-(aminometil)-piperidin benzamidler
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
WO2001010408A3 (de) Wässrige arzneimittelformulierung von moxifloxacin oder salzen davon
CA2235747A1 (en) Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis
WO1999006388A3 (en) Pharmaceutical compounds isolated from aristolochia taliscana
WO1996022305A3 (en) Modified peptides
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
BR9811821A (pt) 2-acilaminopropanaminas como antagonistas de receptores de taquicinina
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
FR2742048B1 (fr) Utilisation de l'alpha-cyano-beta, beta-diphenylacrylate de 2-ethylhexyle pour ameliorer la stabilite de compositions cosmetiques contenant le p-methyl-benzylidene camphre en association avec un derive de dibenzoylmethane
WO1996031208A3 (de) Verwendung von substituierten piperidin- oder pyrrolidinverbindungen zur behandlung von sigma-rezeptor modulierten krankheiten
WO2002005801A3 (en) Compositions containing diacyltartaric salts of (e)-metanicotine
NZ220195A (en) 2-pyridyl-penem derivatives and pharmaceutical compositions
JO2031B1 (ar) عنوان الاختراع:
WO2000033788A3 (en) Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
CA2309439A1 (en) 3-(3-hydroxyphenyl)-3-amino-propionamide derivatives